Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Europe Has Hot Start On Remdisivr, Chinese Car News, Ignoring Global Covid-19 Spik

Published 13/07/2020, 09:03
Updated 21/10/2020, 09:15

Following a muddled, rocky week, Monday got off to a spritely start, as investors turned a blind eye to the bulk of the latest covid-19 headlines, instead cherry picking the most optimistic news items – pretty much a requirement at the moment if you want to see some green.

Firstly, the bad news. The WHO has just reported a record increase in global coronavirus cases, with the USA, Brazil, India and South Africa helping to drive 230,370 new cases in the space of 24 hours.

In the United States specifically Florida finds itself slipping further and further into a truly scary situation, with 15,299 new cases on Sunday – no state has seen a higher one-day figure since covid-19 reached American shores.

And any long-term hopes for ‘herd immunity’ – a buzz phrase at the start of the pandemic, especially in the UK – were dealt a major blow, with tests showing the number of antibodies in people who have recovered from covid-19 fall below immunity levels after a few months.

BUT, Chinese car sales were up 11.61% year-on-year, so phew, crisis averted.

Granted, with a 3rd month of consecutive growth, that bodes well for Thursday’s 2nd quarter GDP reading, which could show the Chinese economy bouncing back by 2.2%, from Q1’s 6.8% contraction.

And it wasn’t just the Chinese automobile industry giving the markets a boost. The latest trial results from Gilead (NASDAQ:GILD) showed further evidence that remdisivr is effective at reducing the risk of death in severely ill coronavirus patients. A shame, then, that the US has secured the world stock of the antiviral drug until the start of October at the earliest...

Regardless of the myriad reasons not to, Europe came out of the gates hot. The FTSE shot up 1.5%, putting 6200 back in its sights, with the DAX crossing 12800 following a 190 point climb, and the CAC passing 5000 on the back of a 1.3% rise.

Currently the Dow Jones is heading for a slighter tamer open, though a 0.7% increase would still lift it above 26250.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.